The Adenosine Receptor Agonist, APNEA, Increases Calcium Influx into Rat Cortical Synaptosomes Through N-type Channels Associated with A2a Receptors

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2000 May 24

PMID 10823578

Citations 5

Authors

S N Li

P T Wong

Affiliations

Soon will be listed here.

Abstract

N6-2-(4-aminophenyl)ethyladenosine (APNEA) is a nonselective adenosine receptor agonist known to have a high affinity for the adenosine A1 and A3 receptors. It was found to be able to dose-dependently increase the sustained (4 min) Ca2+ influx into rat cortical synaptosomes while 2-chloro-N6-(3-iodobenzyl)-adenosine-5-N-methyluronamide (Cl-IB-MECA), a selective A3 agonist has no effect. However, this effect of APNEA was not affected by the presence of 8-cyclopentyl-1,3-dimethylxanthine (CPT), a selective A1 antagonist; but instead completely abolished by 8-(3-chlorostyryl)caffeine (CSC), a selective A2a antagonist, or omega-conotoxin GVIA. These results show that in the rat cortex, presynaptic A2a receptors can mediate neurotransmitter release by increasing Ca2+ influx through the N-type calcium channels. A1 and A3 receptors appear not to be involved.

Citing Articles

Amino acid-based supramolecular chiral hydrogels promote osteogenesis of human dental pulp stem cells via the MAPK pathway.

Li P, Jin Q, Zeng K, Niu C, Xie Q, Dong T Mater Today Bio. 2024; 25:100971.

PMID: 38347936 PMC: 10859303. DOI: 10.1016/j.mtbio.2024.100971.

Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.

Oliveira-Giacomelli A, Naaldijk Y, Sarda-Arroyo L, Goncalves M, Correa-Velloso J, Pillat M Front Pharmacol. 2018; 9:325.

PMID: 29692728 PMC: 5902708. DOI: 10.3389/fphar.2018.00325.

A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development.

Jones K, Choi U, Gao J, Thompson R, Rodman L, Malech H Sci Rep. 2017; 7:44816.

PMID: 28317879 PMC: 5357845. DOI: 10.1038/srep44816.

Photomodulation of G protein-coupled adenosine receptors by a novel light-switchable ligand.

Bahamonde M, Taura J, Paoletta S, Gakh A, Chakraborty S, Hernando J Bioconjug Chem. 2014; 25(10):1847-54.

PMID: 25248077 PMC: 4198106. DOI: 10.1021/bc5003373.

Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors.

Mojsilovic-Petrovic J, Jeong G, Crocker A, Arneja A, David S, Russell D J Neurosci. 2006; 26(36):9250-63.

PMID: 16957081 PMC: 6674510. DOI: 10.1523/JNEUROSCI.1856-06.2006.

References

Jacobson K, van Galen P, Williams M . Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem. 1992; 35(3):407-22. PMC: 3476067. DOI: 10.1021/jm00081a001. View

Correia-de-Sa P, Ribeiro J . Evidence that the presynaptic A2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase. Naunyn Schmiedebergs Arch Pharmacol. 1994; 350(5):514-22. DOI: 10.1007/BF00173021. View

Kohno Y, Ji X, Mawhorter S, Koshiba M, Jacobson K . Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood. 1996; 88(9):3569-74. PMC: 5472057. View

Cunha R, Milusheva E, Vizi E, Ribeiro J, Sebastiao A . Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus. J Neurochem. 1994; 63(1):207-14. DOI: 10.1046/j.1471-4159.1994.63010207.x. View

Zhou Q, Li C, Olah M, Johnson R, Stiles G, Civelli O . Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci U S A. 1992; 89(16):7432-6. PMC: 49724. DOI: 10.1073/pnas.89.16.7432. View

Mogul D, Adams M, Fox A . Differential activation of adenosine receptors decreases N-type but potentiates P-type Ca2+ current in hippocampal CA3 neurons. Neuron. 1993; 10(2):327-34. DOI: 10.1016/0896-6273(93)90322-i. View

Linden J . Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci. 1994; 15(8):298-306. DOI: 10.1016/0165-6147(94)90011-6. View

Ralevic V, Burnstock G . Receptors for purines and pyrimidines. Pharmacol Rev. 1998; 50(3):413-92. View

Cunha R, Vizi E, Ribeiro J, Sebastiao A . Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem. 1996; 67(5):2180-7. DOI: 10.1046/j.1471-4159.1996.67052180.x. View

10.

Kim H, Ji X, Siddiqi S, Olah M, Stiles G, Jacobson K . 2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors. J Med Chem. 1994; 37(21):3614-21. PMC: 3468333. DOI: 10.1021/jm00047a018. View

11.

van Galen P, van Bergen A, Melman N, Olah M, IJzerman A, Stiles G . A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol Pharmacol. 1994; 45(6):1101-11. PMC: 3479652. View

12.

Umemiya M, Berger A . Activation of adenosine A1 and A2 receptors differentially modulates calcium channels and glycinergic synaptic transmission in rat brainstem. Neuron. 1994; 13(6):1439-46. DOI: 10.1016/0896-6273(94)90429-4. View

13.

Coutinho O, Carvalho C, Carvalho A . Calcium uptake related to K+-depolarization and Na+/Ca2+ exchange in sheep brain synaptosomes. Brain Res. 1984; 290(2):261-71. DOI: 10.1016/0006-8993(84)90943-0. View

14.

Gubitz A, Widdowson L, Kurokawa M, Kirkpatrick K, Richardson P . Dual signalling by the adenosine A2a receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals. J Neurochem. 1996; 67(1):374-81. DOI: 10.1046/j.1471-4159.1996.67010374.x. View

15.

Fleming K, Mogul D . Adenosine A3 receptors potentiate hippocampal calcium current by a PKA-dependent/PKC-independent pathway. Neuropharmacology. 1997; 36(3):353-62. DOI: 10.1016/s0028-3908(97)83762-8. View

16.

Goncalves M, Ribeiro J . Adenosine A2 receptor activation facilitates 45Ca2+ uptake by rat brain synaptosomes. Eur J Pharmacol. 1996; 310(2-3):257-61. DOI: 10.1016/0014-2999(96)00383-4. View

17.

Stiles G, Daly D, Olsson R . Characterization of the A1 adenosine receptor-adenylate cyclase system of cerebral cortex using an agonist photoaffinity ligand. J Neurochem. 1986; 47(4):1020-5. DOI: 10.1111/j.1471-4159.1986.tb00715.x. View

18.

Fozard J, Carruthers A . Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br J Pharmacol. 1993; 109(1):3-5. PMC: 2175589. DOI: 10.1111/j.1476-5381.1993.tb13522.x. View

19.

Fredholm B, Abbracchio M, Burnstock G, Daly J, Harden T, Jacobson K . Nomenclature and classification of purinoceptors. Pharmacol Rev. 1994; 46(2):143-56. PMC: 4976594. View

20.

ORegan M, Simpson R, Perkins L, Phillis J . The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci Lett. 1992; 138(1):169-72. DOI: 10.1016/0304-3940(92)90498-v. View